Neudle.com: alpha agonists

Neurology Specific Literature Search

Differential
(Click to cross reference)

activated protein C resistance

acute intermittant porphyria

addiction, heroin

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

alcoholic withdrawal states, DT's, convulsions, etc.

allergic angiitis

alpha-fetoprotein

alpha-synuclein

Alzheimer's disease

Alzheimer's disease, treatment of

amphetamines, dyskinesia associated with

anemia, hemolytic

anesthesia, general

anesthesia, local

angiitis, granulomatous of CNS

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, posterior fossa

antiarrhythmic drugs

antibiotics, neurologic complications with

anticoagulant, complications of

anticoagulant, restarting

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, blood level determination of

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

antiphospholipid antibodies

antithrombin III deficiency

arterial dissection

arterial dissection, carotid

arterial dissection, multiple

arterial dissection, vertebral

atherosclerosis, premature

atrial septal aneurysm

attention deficit disorder with hyperactivity

autistic behavior

autonomic dysfunction

axonal degeneration

basal ganglia, infarction

basal ganglia, lesion of

behavior modification

behavioral disorder

benign sexual headache

beta adrenergic blocker

blood dyscrasias, neurologic findings with

botulinum toxin

Budd-Chiari Syndrome

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

calcium antagonist

calcium antagonist, side effects of

cancer, cerebrovascular accident complicating patients with

cardiovascular disease

carotid angiogram

carotid artery atherosclerosis

carotid artery disease

carotid artery stenosis

carotid artery stenosis, intracranial

CAT scan, abdomen

CAT scan, abnormal

CAT scan, angiography

CAT scan, cord sign

CAT scan, hyperattenuation

CAT scan, venography

cavernous sinus, syndrome

cavernous sinus, thrombosis

central retinal artery occlusion

cerebellar hemorrhage

cerebellar infarction

cerebral edema, origin and treatment

cerebral embolism

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, atrial myxoma

cerebrovascular accident, complications with

cerebrovascular accident, cryptogenic

cerebrovascular accident, differential diagnosis of

cerebrovascular accident, etiology

cerebrovascular accident, non atherosclerotic cause of

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, sex distribution

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, predisposed factor in

cerebrovascular disease, risk factors in

cerebrovascular disease, smoking in

cervical spine injury

cervical spine manipulation

Chiari Frommel syndrome

chiropractic manipulation

cigarette smoking

Clinical Pathologic Conference(C.P.C.)

cluster headache

collagen vascular disease

complement, serum

congenital birth defects

congenital malformation

congenital malformation, non CNS

congestive heart failure

controversies in neurology

corneal dystrophy

corpus callosum, infarction of

cortical vein thrombosis

cost effectiveness

coumarin, restarting treatment

craniectomy, decompressive

cryofibrinogenemia

deafness, unilateral

delay in diagnosis

delivery, complicated

developmental retardation

diabetes insipidus

diabetes mellitus

diabetes mellitus, chemical

diagnostic criteria

differential diagnosis

difficulty climbing stairs

disseminated intravascular coagulation(DIC)

diurnal variation

dopamine agonist

dopamine antagonist

downward deviation of eyes

drug abuse, neurologic complications of

drug induced neurologic disorders

drug interactions

drug withdrawal

dural arteriovenous malformation

dural sinus thrombosis

Durett hemorrhages

dyskinesia, buccal lingual facial

edema, periorbital

electroencephalogram, abnormalities of

empty sella syndrome

endovascular therapy

enzyme, induction

epidemiology of neurology

episodic disorders

erythropoietin treatment

evidence-based research

eye movement, painful

facial weakness, bilateral

Factor V Leiden

factor Xa inhibitor

fibrinolytic agents

fibrinolytic agents, intra-venous local infusion

fibromuscular dysplasia

fine motor function, impaired

flow study, cerebral

genetic counselling

genetic neurologic disorders

Gilles de la Tourette syndrome

glucose tolerance test, abnormal

hallucination, auditory

hallucination, olfactory

headache, children

headache, drug induced

headache, episodic

headache, progressive

headache, prophylaxis

headache, recurrent

headache, severe

headache, sudden onset of

headache, throbbing

headache, thunderclap

headache, treatment of

headache, unilateral

headache, vascular

headache, worst of life

hearing loss, sudden, unilateral

heart wall motion dysfunction

hematoma, intracerebral

hemoglobin abnormality, neurologic complications of

heralding manifestation

hormone replacement

hormone therapy

hypercoagulable state

hypereosinophilic syndrome(HES)

hyperhidrosis, unilateral

hypertension, paroxysmal

hypocomplementemia

hypoosmolality of serum

ileus, paralytic

imbalance, postural

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inclusion bodies

internal cerebral vein

intracerebral hemorrhage

intracerebral hemorrhage, multiple

intracerebral hemorrhage, young adult

intracranial hypertension, benign

intracranial hypertension, benign, incidence of

intracranial pressure, increased

Korsakoff's psychosis

labor, complicated

lactic dehydrogenase(LDH)

lateral sinus thrombosis

L-dopa, drug interactions with and side effects of

LE cell preparation

learning disability, in children

level of consciousness, decreased

Lewy body disease, diffuse

lidocaine, intravenous

lumbar puncture, complications of

Maffucci's syndrome

May-Thurner syndrome

memory, disorder, treatment of

menses, seizure with

mental status, abnormal

methylphenidate

migraine with aura

migraine, children

migraine, menses

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

monoamine oxidase inhibitors

monoclonal antibodies

movement disorder

movement disorder, drug induced

moyamoya, adult

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, false negative

MRI, false positive

MRI, venography

multiple sclerosis

multiple sclerosis, risk factors for

multiple system atrophy

muscle weakness

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

myocardial infarction

nausea and vomiting

neoplasm, pituitary

neoplasm, pituitary, treatment of

neurocardiology

neuroleptic, atypical

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic symptoms

neuromuscular blockade

neuropathology, brain

neuropathy, etiologies of

neuropathy, painful

neuropathy, peripheral, treatment

neuroprotective agents

neurotransmitter

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

obsessive-compulsive disorder

obstetric neurologic injuries

Ollier's disease(enchondromas, multiple)

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, choreiform movements with

oral contraceptives, neurologic complications with

otitis, neurologic complications with

outcome research

ovarian induction

pain, abdominal

pain, management of chronic

pain, neuropathic

Parkinson disease

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, etiology of

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, treatment of

Parkinsonism multiple-system atrophy

paroxysmal nocturnal hemoglobinuria

patent foramen ovale

patient information and support

pelvic deep venous thrombosis

periarteritis nodosa

persistent eustacian valve

personality change

phenothiazine, dyskinesia associated with

physical activity

pituitary, adenoma

pituitary, microadenoma

platelet inhibiting drugs

post herpetic neuralgia

posterior fossa

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premonitory urges

prenatal diagnosis by amniocentesis

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

primary thrombocythemia

progressive neurologic disorder

prolactin, elevated

protein C deficiency

protein S deficiency

psychiatric problems in neurologic disorders

psychosis, acute

psychotic behavior

pulmonary embolism

quadriparesis, progressive

quality of life

remote effect of cancer on the nervous system

restless leg syndrome

reversible cerebral vasoconstrictive syndromes

rheumatic heart disease

risk-benefit assessment

seizure, classification of

seizure, diagnosis of

seizure, diencephalic

seizure, non-treatment of

seizure, pregnancy

seizure, psychomotor-temporal lobe

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, withdrawal

seizure, workup of

selective serotonin reuptake inhibitors

sensorineural hearing loss

serotonin agonist

sexual intercourse

sickle cell trait

single photon emission computed tomography

skull x-ray, abnormal

sleep pathology and physiology

splenic-vein thrombosis

stem cell transplantation

steroid therapy, CNS treatment and complications with

stimulant drugs

stimulation, deep brain

strokelike episodes

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

superior petrosal sinus

superior sagittal sinus thrombosis

symmetric brain lesions

synucleinopathy

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, drug induced

Takotsubo cardiomyopathy

tardive dyskinesia

temporal lobe, lesion

teratogenic drugs

tetanus antitoxin

thalamus, infarction of

thalamus, lesion of

thalamus, lesion of-bilateral

throat-clearing

thrombocytopenia

thrombophlebitis

thrombosis, cerebral

tic, chronic multiple

tic, classification of

tissue plasminogen activator, intravenous

transient ischemic attack

treatment of neurologic disorder

tricyclic antidepressant

trifluoperazine

trigeminovascular system

ulcerative colitis

ultrasonography

ultrasonography, head, fetus-neonate

upgaze, paralysis of

urine osmolality, elevated

vagus nerve stimulation

vasospasm, cerebral

venogram, cerebral

venous thrombosis, non-cerebral

viral infection, CNS

vision, blurred

visual field defect

vitamin supplementation

watershed infarcts

Watson-Schwartz reaction

weakness, generalized

weakness, progressive

Showing articles 500 to 550 of 687 << Previous Next >>

The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995

Oral Sumatriptan in Prevent Headache Recurr after Trmt of Migraine with Subcut Sumatriptan
Neurol 45:1505-1509, Rappoport,A.M.,et al, 1995

Oral Sumatriptan for the Acute Treatment of Migraine:Eval of Three Dosage Strengths
Neurol 45:S5-S9, Cutler,N.,et al, 1995

Oral Sumatriptan is Effective & Well Tolerated for the Acute Trmt of Migraine:A Multictr Study
Neurol 45:S10-S14, S31995., Sargent,J.,et al, 1995

Oral Sumatriptan for the Long-Term Treatment of Migraine:Clinical Findings
Neurol 45:S15-S20, Rederich,G.,et al, 1995

Cardiac Arrest Following the Use of Sumatriptan
Neurol 45:1211-1213, Kelly,K.M., 1995

Hepatitis C Infection, Cryoglobulinemia, and Vasculitic Neuropathy. Treatment with Interferon Alfa:Case Rpt & Literat Review
Neurol 45:407-411, Khella,S.L.,et al, 1995

The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995

Analgesic Headache
BMJ 310:479-480, Olesen,J., 1995

Drugs for Migraine
The Medical Letter 37:17-20, , 1995

Clinical Exper from Sweden on Use of Subcutaneously Admin Sumatriptan in Migraine & Cluster Headache
Arch Neurol 51:1256-1261, Dahlof,C.,et al, 1994

Migraine:A Pharmacologic Review with Newer Options and Delivery Modalities
Neurol 44:S13-S17, Baumel,B., 1994

Subcutaneous Sumatriptan During the Migraine Aura
Neurol 44:1587-1592, Bates,D.,et al, 1994

Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994

A Multicenter Double-Blind Placebo-Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease
Movement Disorders, 9:40-471994., Olanow,C.W.,et al, 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

Is There a Problem with Long Term Use of Sumatriptan in Acute Migraine?
BMJ 308:113, Osborne,M.J.,et al, 1994

X1-Antitrypsin Deficiency in Intracranial Aneurysms and Cervical Artery Dissection
Lancet 343, 452-4531994., Schievink,W.I.,et al, 1994

Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994

Fluctuating Parkinson's Disease:Treatment with the Long-Acting Dopamine Agonist Cabergoline
Arch Neurol 51:1236-1241, Ahlskog,J.E.,et al, 1994

Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993

Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993

Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993

Postmarketing Study of Cardiovascular Adverse Reactions Associated with Sumatriptan
BMJ 307:1185, Ottervanger,J.P.,et al, 1993

Cabergoline in Parkinson's Disease:Long-Term Follow-up
Neurol 43:2587-2590, Lera,G.,et al, 1993

Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa
Neurol 43:1981-1984, Lieberman,A.,et al, 1993

Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993

Sumatriptan and Chest Pain
Lancet 341:1564-1565, Hillis,W.S.&MacIntyre,P.D., 1993

Transmural Myocardial Infarction with Sumatriptan
Lancet 341:861-862, Ottervanger,J.P.,et al, 1993

Efficacy of Subcutaneous Sumatriptan in Repeated Episodes of Migraine
Neurol 43:1363-1368, Cady,R.K.,et al, 1993

Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993

Defecatory Function in Parkinson's Disease:Response to Apomorphine
Ann Neurol 33:490-493, Edwards,L.L.,et al, 1993

Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992

Dose Ranging Efficacy & Safety of Subcut Sumatriptan in Acute Treat of Migraine
Arch Neurol 49:1271-1276, Mathew,N.T.,et al, 1992

Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992

Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992

An Open-Label Trial of Bromocriptine in Nonfluent Aphasia
Neurol 42:1637-1638, Sabe,L.,et al, 1992

Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992

Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992

Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992

Acute Respiratory Failure from Dopamine Agonist Withdrawal
Neurol 42:1843-1844, Riley,D.E.,et al, 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991

A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991

Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991

The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991

Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991

Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991

Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991

Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group, NEJM 325:316-321, 353-354991., , 1991

Showing articles 500 to 550 of 687 << Previous Next >>